Investigation of COVID-19 By Theoretical Docking of Medicines With Two Proteins

Protein-Ligand In- Silico Molecular Docking Model for Discovering Potential Drugs of COVID-19

Potential chemical compounds can inhibit SARS CoV-2 replication and open the way for the production of anti-SARS CoV-2 therapy.

Discovery and Synthesis of Novel Bio-Isostere of Purine Analogues Inhibiting SARS-CoV-2

In Vitro Assessment of a Natural Monoterpene as an Antiviral Compound against Low Pathogenic Human Coronavirus 229E

Synthesis and In silico Docking Study of Some New Quinazolin-2,4-diones Targeting COVID-19 (SARS-Cov-2) Main Protease: A Search for Anti-Covid19 Drug Candidates

Antiviral Effect of Curcuminoids and Curcumin Derivatives Against Coronavirus (Sars-Cov-2) Predicted Using Molecular Docking Approach

Citrus clementine peels essential oil exhibited anti-SARS-CoV-2 and its modulatory effect against cytokine storm: Evidence from in vitro and in silico studies

Synthesis, Characterization and In silico Molecular Docking Studies of Novel Chromene Derivatives as Rab23 Inhibitors

Docking Study of HIV-1 Reverse Transcriptase (HIV-1 RT) with Well-Known Nucleoside Reverse Transcriptase Inhibitors (NRTIs)